Evidence map›Paper›PMID 33301346›Full record

ReviewExpert review of molecular diagnostics2020

Assessing our approach to diagnosing Fibromyalgia.

Kevin Hackshaw

Abstract readReview
In one paragraph

Review in Expert review of molecular diagnostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Fibromyalgia interventions, obstacles and prospects: narrative review.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2023
    Review
  10. Review
  11. New Clinical Phenotype of the Post-Covid Syndrome: Fibromyalgia and Joint Hypermobility Condition.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Article
  12. Review
  13. The Search for Biomarkers in Fibromyalgia.Diagnostics (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kevin HackshawDivision Chief of Rheumatology, Department of Internal Medicine, Division of Rheumatology, Dell Medical School, the University of Texas , Austin, TX, USA.

Funding

Objective tests utilizing Vibrational Spectroscopy for Diagnosis and Severity of Fibromyalgia and Related Pain SyndromesR61NS117211 · NINDS · UNIVERSITY OF TEXAS AT AUSTIN · PI HACKSHAW, KEVIN VICTOR, RODRIGUEZ-SAONA, LUIS E · 2020 to 2020
$1.5M
NINDS NIH HHS R61 NS117211
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersClinical Decision-MakingDiagnostic Tests, RoutineDisease ManagementFibromyalgiaHumansReproducibility of ResultsSensitivity and SpecificityUnited StatesBiomarkersACR diagnostic criteriacentral sensitivitychronic widespread painFibromyalgiatender point

Identifiers

PMID33301346
PMCPMC11829810

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.